Current Status of CPX-351 Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference32 articles.
1. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006
2. Acute myeloid leukemia–major progress over four decades and glimpses into the future;Kantarjian;Am J Hematol,2016
3. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm–combined prospective analysis by the German AML Intergroup;Buchner;J Clin Oncol,2012
4. Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study;Castaigne;Lancet,2012
5. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation;Stone;N Engl J Med,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions;Biomedicines;2024-04-29
2. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05
3. Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax;Pharmaceutics;2024-01-31
4. Clinical decision-making and treatment of myelodysplastic syndromes;Blood;2023-12-28
5. A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives;Mini-Reviews in Medicinal Chemistry;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3